Friday, October 30, 2026

LendingTree Stock Soars 32% In Last 21 Sessions: What's Driving The Surg

LendingTree Stock Soars 32% In Last 21 Sessions: What's Driving The Surg

(VIANEWS) - LendingTree (NASDAQ: TREE) shares have experienced an astounding 32.86% gain since August 16, rising from EUR32.62 to EUR43.34 over 21 sessions - marking three straight sessions of gains for this stock and 0.2% overall increase to EUR16,401.84 on four occasions since August 16. At its last close on October 29th LendingTree closed at 1.95% higher than its 52-week high of EUR42.51!

About LendingTree

LendingTree, Inc. is a premier consumer platform operating across three divisions: Home, Consumer and Insurance. Home services provided by mortgage and real estate providers; while Consumer offerings include credit cards, personal loans, deposit accounts and other forms of credit products. The Insurance segment provides insurance quote products, access to lead aggregators and comparison tools through ValuePenguin for personal financial analysis. LendingTree also offers Stash, a consumer investing and banking platform with personal investment accounts and banking services for individual consumers. LendingTree was initially founded as Tree.com Inc in 1996 with its headquarters located in Charlotte North Carolina.

Yearly Analysis

Yearly Top and Bottom ValueLendingTree's stock currently trades at EUR43.34, exceeding its 52-week high of EUR42.51 by over 3%. Recent Stock PerformanceAccording to analyst projections, LendingTree is projected to experience negative sales growth this year of 0.4%. However, next year's sales growth is anticipated to reach 16%, suggesting an impressive improvement. Earnings Before Interest, Taxes, Depreciation and AmortizationLendingTree has an EBITDA figure of EUR1.55, indicating positive net income after accounting for interest, taxes, depreciation and amortization expenses. Investment OutlookBased on this information, LendingTree appears to be an attractive investment with strong financial credentials and an optimistic outlook. Recent performance and expected growth suggest that AIG stock could be an attractive investment option for those in the financial services sector, however it is essential to conduct further research and analysis prior to making any definitive investments decisions.

Technical Analysis

LendingTree, an online marketplace for financial services, has seen its stock price rapidly surge over recent days, breaching both 50-day and 200-day moving averages with ease. This can only be taken as a positive sign, suggesting sustained growth of the stock. But it should be noted that today's reported volume of 283,494 is lower than its average daily volume of 334,041, which could indicate traders taking profits or being uncertain of its future prospects. Furthermore, stock volatility has also been relatively high over recent weeks with an average intraday variation rate of 2.60% being significantly above industry norms. Though not yet profitable, the stochastic oscillator, an indicator of overbought and oversold conditions, indicates that this stock may currently be oversold with an oscillator value below 20, providing investors an opportunity to capitalize on its future potential growth potential.

Quarter Analysis

LendingTree's sales growth for this quarter stands at negative 19% and their projected quarterly growth for next quarter is set to decrease further to negative 12.9%. Growth estimates for current quarter are 44% with further reduction of 44.7% expected for subsequent quarters. Year-on-year quarterly revenue growth has dropped 33.5% with total twelve trailing month revenues currently standing at 672.5 Million USD.

Equity Analysis

As per available information, LendingTree's trailing twelve months EPS stands at EUR-9.46 and indicates that its shareholders are not reaping profits at present. LendingTree's return on equity (ROE) for the past twelve months stands at negative 73.72%, suggesting it has failed to produce profits for shareholders relative to their equity investment in the company. Investors should carefully consider this information when evaluating LendingTree as a potential investment option. Negative EPS and ROE ratios could signal financial instability and pose risks to investors, so further investigation and analysis should be performed prior to making any decisions on investment opportunities.

More news about LendingTree (TREE).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com